ACETAMINOPHEN's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8741959 | FRESENIUS KABI USA | Paracetamol for parenteral administration |
Apr, 2030
(6 years from now) | |
Acetaminophen is owned by Fresenius Kabi Usa.
Acetaminophen contains Acetaminophen.
Acetaminophen has a total of 1 drug patent out of which 0 drug patents have expired.
Acetaminophen was authorised for market use on 28 October, 2015.
Acetaminophen is available in solution;intravenous dosage forms.
The generics of Acetaminophen are possible to be released after 19 April, 2030.
Drugs and Companies using ACETAMINOPHEN ingredient
Market Authorisation Date: 28 October, 2015
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
ACETAMINOPHEN family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic